Long-lasting alterations of the immune system by ionizing radiation exposure: Implications for disease development among atomic bomb survivors

International Journal of Radiation Biology

Volumn 84, Issue 1, 2008, Pages 1-14

  Kusunoki, Yoichiro ^a   Hayashi, Tomonori ^a  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

Atom bomb effects; Cytokines; Epidemiology; Flow cytometry; Immunology; Inflammation

Indexed keywords

INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGENIC AGENT;

AGING; ATOMIC BOMB; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL RENEWAL; CELLULAR IMMUNITY; CYTOKINE RELEASE; DISEASE COURSE; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNE FUNCTION TEST; IMMUNE SYSTEM; INFLAMMATION; IONIZING RADIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; SURVIVOR; TH1 CELL; TH2 CELL;

HUMANS; IMMUNE SYSTEM; NUCLEAR WARFARE; NUCLEAR WEAPONS; RADIATION INJURIES; RADIATION, IONIZING; SURVIVORS; T-LYMPHOCYTE SUBSETS;

EID: 36749050926     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000701616106     Document Type: Review

References (65)

1. Akiyama M. 1995. Late effects of radiation on the human immune system: an overview of immune response among the atomicbomb survivors. International Journal of Radiation Biology 68:497-508.
2. Akiyama M, Kusunoki Y, Kyoizumi S, Ozaki K, Mizuno S, Cologne JB. 1993. Study of the titers of anti-Epstein-Barr virus antibodies in the sera of atomic bomb survivors. Radiation Research 133:297-302.
3. Akiyama M, Yamakido M, Kobuke K, Dock DS, Hamilton HB, Awa AA, Kato H. 1983. Peripheral lymphocyte response to PHA and T cell population among atomic bomb survivors. Radiation Research 93:572-580.
4. Akiyama M, Zhou OL, Kusunoki Y, Kyoizumi S, Kohno N, Akiba S, Delongchamp RR. 1989. Age and dose related alteration of in vitro mixed lymphocyte culture response of blood lymphocytes from A-bomb survivors. Radiation Research 117:26-34.
5. Awa AA. 1991. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki. Journal of Radiation Research (Tokyo) 32(Suppl.):265-274.
6. Bloom ET, Akiyama M, Korn EL, Kusunoki Y, Makinodan T. 1988. Immunological responses of aging Japanese A-bomb survivors. Radiation Research 116:343-355.
7. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Tracy RP, Rubin SM, Harris TB, Pahor M. 2003. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). American Journal of Cardiology 92:522-528.
8. Cosmi L, Annunziato F, Galli MIG, Maggi RME, Nagata K, Romagnani S. 2000. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. European Journal of Immunology 30:2972-2979.
9. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. 2000. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal 321:199-204.
10. Fujiwara S, Carter RL, Akiyama M, Akahoshi M, Kodama K, Shimaoka K, Yamakido M. 1994. Autoantibodies and immunoglobulins among atomic bomb survivors. Radiation Research 137:89-95.
11. Fujiwara S, Kusumi S, Cologne J, Akahoshi M, Kodama K, Yoshizawa H. 2000. Prevalence of anti-hepatitis C virus antibody and chronic liver disease among atomic bomb survivors. Radiation Research 154:12-19.
12. Fujiwara S, Sharp GB, Cologne JB, Kusumi S, Akahoshi M, Kodama K, Suzuki G, Yoshizawa H. 2003. Prevalence of hepatitis B virus infection among atomic bomb survivors. Radiation Research 159:780-786.
13. Goldrath AW, Bevan MJ. 1999. Selecting and maintaining a diverse T-cell repertoire. Nature 402:255-262.
14. Hakoda M, Akiyama M, Kyoizumi S, Awa AA, Yamakido M, Otake M. 1988. Increased somatic cell mutant frequency in atomic bomb survivors. Mutation Research 201:39-48.
15. Hakoda M, Hirai Y, Shimba H, Kusunoki Y, Kyoizumi S, Kodama Y, Akiyama M. 1989. Cloning of phenotypically different human lymphocytes originating from a single stem cell. Journal of Experimental Medicine 169:1265-1276.
16. Hakoda M, Kasagi F, Kusunoki Y, Matsuura S, Hayashi T, Kyoizumi S, Akahoshi M, Suzuki G, Kodama K, Fujiwara S. 2006. Levels of antibodies to microorganisms implicated in atherosclerosis and of C-reactive protein among atomic bomb survivors. Radiation Research 166:360-366.
17. Hayashi T, Fujiwara S, Morishita Y, Kusunoki Y, Nakashima E, Nakanishi S, Suzuki G, Nakachi K, Kyoizumi S. 2003a. HLA haplotype is associated with diabetes among atomic bomb survivors. Human Immunology 64:910-916.
18. Hayashi T, Kusunoki Y, Hakoda M, Morishita Y, Kubo Y, Maki M, Kasagi F, Kodama K, Macphee DG, Kyoizumi S. 2003b. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. International Journal of Radiation Biology 79:129-136.
19. Hayashi T, Morishita Y, Kubo Y, Kusunoki Y, Hayashi I, Kasagi F, Hakoda M, Kyoizumi S, Nakachi K. 2005. Radiation dose-dependent aging of inflammatory status in association with enhanced humoral immunity in atomic bomb survivors. American Journal of Medicine 118:83-86.
20. Hirokawa K, Utsuyama M, Kasai M, Kurashima C. 1992. Aging and immunity. Acta Pathologica Japonica 42:537-548.
21. Imaizumi M, Usa T, Tominaga T, Neriishi K, Akahoshi M, Nakashima E, Ashizawa K, Hida A, Soda M, Fujiwara S, Yamada M, Ejima E, Yokoyama N, Okubo M, Sugino K, Suzuki G, Maeda R, Nagataki S, Eguchi K. 2006. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. Journal of American Medical Association 295:1011-1022.
22. Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nature Immunology 5:987-995.
23. Kato H, Mayumi M, Nishioka K, Hamilton HB. 1983. The relationship of hepatitis B surface antigen and antibody to atomic bomb radiation in the Adult Health Study sample, 1975-1977. American Journal of Epidemiology 117:610-620.
24. Kodama K, Fujiwara S, Yamada M, Kasagi F, Shimizu Y, Shigematsu I. 1996a. Profiles of non-cancer diseases in atomic bomb survivors. World Health Statistics Quarterly 49:7-16.
25. Kodama K, Mabuchi K, Shigematsu I. 1996b. A long-term cohort study of the atomic-bomb survivors. Journal of Epidemiology 6:S95-105.
26. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. 1999. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99:237-242.
27. Kusunoki Y, Akiyama M, Kyoizumi S, Bloom ET, Makinodan T. 1988. Age-related alteration in the composition of immunocompetent blood cells in atomic bomb survivors. International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine 53:189-198.
28. Kusunoki Y, Hayashi T, Morishita Y, Yamaoka M, Maki M, Bean MA, Kyoizumi S, Hakoda M, Kodama K. 2001. T-cell responses to mitogens in atomic bomb survivors: A decreased capacity to produce interleukin 2 characterizes the T cells of heavily irradiated individuals. Radiation Research 155:81-88.
29. Kusunoki Y, Kodama Y, Hirai Y, Kyoizumi S, Nakamura N, Akiyama M. 1995. Cytogenetic and immunologic identification of clonal expansion of stem cells into T and B lymphocytes in one Atomic-bomb survivor. Blood 86:2106-2112.
30. Kusunoki Y, Kyoizumi S, Hirai Y, Suzuki T, Nakashima E, Kodama K, Seyama T. 1998. Flow cytometry measurements of subsets of T, B and NK cells in peripheral blood lymphocytes of atomic bomb survivors. Radiation Research 150:227-236.
31. Kusunoki Y, Kyoizumi S, Yamaoka M, Kasagi F, Kodama K, Seyama T. 1999. Decreased proportion of CD4 T cells in the blood of atomic bomb survivors with myocardial infarction [published erratum appears in Radiation Research 2000 154:119]. Radiation Research 152:539-543.
32. Kusunoki Y, Yamaoka M, Kasagi F, Hayashi T, Koyama K, Kodama K, MacPhee DG, Kyoizumi S. 2002a. T cells of atomic bomb survivors respond poorly to stimulation by Staphylococcus aureus toxins in vitro: Does this stem from their peripheral lymphocyte populations having a diminished naive CD4 T-cell content? Radiation Research 158:715-724.
33. Kusunoki Y, Hirai Y, Hakoda M, Kyoizumi S. 2002b. Uneven distributions of naive and memory T cells in the CD4 and CD8 T-cell populations derived from a single stem cell in an atomic bomb survivor: Implications for the origins of the memory Tcell pools in adulthood. Radiation Research 157:493-499.
34. Kusunoki Y, Yamaoka M, Kasagi F, Hayashi T, MacPhee DG, Kyoizumi S. 2003. Long-lasting changes in the T-cell receptor V beta repertoires of CD4 memory T-cell populations in the peripheral blood of radiation-exposed people. British Journal of Haematology 122:975-984.
35. Kuzmenok O, Potapnev M, Potapova S, Smolnikova V, Rzheutsky V, Yarilin AA, Savino W, Belyakov IM. 2003. Late effects of the Chernobyl radiation accident on T cell-mediated immunity in cleanup workers. Radiation Research 159:109-116.
36. Kyoizumi S, Nakamura N, Hakoda M, Awa AA, Bean MA, Jensen RH, Akiyama M. 1989. Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter. Cancer Research 49:581-588.
37. Langlois RG, Bigbee WL, Kyoizumi S, Nakamura N, Bean MA, Akiyama M, Jensen RH. 1987. Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Science 236:445-448.
38. 4+ Tcell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 89:3700-3707.
39. Mackall CL, Gress RE. 1997. Thymic aging and T-cell regeneration. Immunological Reviews 160:91-102.
40. Mackall CL, Punt JA, Morgan P, Farr AG, Gress RE. 1998. Thymic function in young/old chimeras: Substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. European Journal of Immunology 28:1886-1893.
41. Matsuo T, Nakashima E, Carter RL, Neriishi K, Mabuchi K, Akiyama M, Shimaoka K, Kinoshita K, Tomonaga M, Ichimaru M. 1995. Anti-Human T-lymphotropic virus type-I antibodies in atomic-bomb survivors. Journal of Radiation Research 36:8-16.
42. Mendall MA, Strachan DP, Butland BK, Ballam L, Morris J, Sweetnam PM, Elwood PC. 2000. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. European Heart Journal 21:1584-1590.
43. Miller RA. 1996. The aging immune system: primer and prospectus. Science 273:70-74.
44. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. 1996. The aging of hematopoietic stem cells. Nature Medicine 2:1011-1016.
45. Nagataki S, Shibata Y, Inoue S, Yokoyama N, Izumi M, Shimaoka K. 1994. Thyroid diseases among atomic bomb survivors in Nagasaki. Journal of American Medical Association 272:364-370.
46. Nakano M, Kodama Y, Ohtaki K, Itoh M, Awa AA, Cologne J, Kusunoki Y, Nakamura N. 2004. Estimating the number of hematopoietic or lymphoid stem cells giving rise to clonal chromosome aberrations in blood T lymphocytes. Radiation Research 161:273-281.
47. Neriishi K, Akiba S, Amano T, Ogino T, Kodama K. 1995. Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors. Radiation Research 144:215-221.
48. Neriishi K, Nakashima E, Delongchamp RR. 2001. Persistent subclinical inflammation among A-bomb survivors. International Journal of Radiation Biology 77:475-482.
49. Ohkita T. 1975. Biological effects. A. Acute effects. In: A review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. Journal of Radiation Research (Tokyo) 16(Suppl.):49-66.
50. Oughtersen AW, Warren S. 1956. Hematology of atomic bomb injuries, pathology of atomic bomb injuries. In: Medical effects of the atomic bomb in Japan. National Nuclear Energy Series. Division III. New York: McGraw-Hill. pp 191-430.
51. Park R, Detrano R, Xiang M, Fu P, Ibrahim Y, LaBree L, Azen S. 2002. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 106:2073-2077.
52. Pawelec G, Solana R. 1997. Immunosenescence. Immunology Today 18:514-516.
53. Pierce DA, Mendelsohn ML. 1999. A model for radiation-related cancer suggested by atomic bomb survivor data. Radiation Research 152:642-654.
54. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine 336:973-979.
55. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. 2000. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772.
56. Ridker PM, Stampfer MJ, Rifai N. 2001. Novel risk factors for systemic atherosclerosis: A comparison of C- reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. Journal of American Medical Association 285:2481-2485.
57. Roesch WC. 1987. US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki, Radiation Effects Research Foundation, Hiroshima, Japan.
58. Ross R. 1999. Atherosclerosis - an inflammatory disease. New England Journal of Medicine 340:115-126.
59. Rufer N, Helg C, Chapuis B, Roosnek E. 2001. Human memory T cells: Lessons from stem cell transplantation. Trends in Immunology 22:136-141.
60. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. 2003. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-817.
61. Taniguchi M, Nakayama T. 2000. Recognition and function of Valpha14 NKT cells. Seminars in Immunology 12:543-550.
62. von Herrath MG, Harrison LC. 2003. Antigen-induced regulatory T cells in autoimmunity. Nature Reviews, Immunology 3:223-232.
63. Watanabe N, De Rosa SC, Cmelak A, Hoppe R, Herzenberg LA, Roederer M. 1997. Long-term depletion of naive T cells in patients treated for Hodgkin's disease. Blood 90:3662-3672.
64. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. 2004. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiation Research 161:622-632.
65. Yamaoka M, Kusunoki Y, Kasagi F, Hayashi T, Nakachi K, Kyoizumi S. 2004. Decreases in percentages of naive CD4 and CD8 T cells and increases in percentages of memory CD8 Tcell subsets in the peripheral blood lymphocyte populations of A-bomb survivors. Radiation Research 161:290-298.